HCA Healthcare Stock - Chart picture and volatility check on a Thursday

HCA Healthcare stock trades near recent highs on the New York Stock Exchange while volatility remains moderate. This Thursday update looks at the technical picture, recent price ranges and how the hospital operator makes its money.

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 21:31 CET. Details in the imprint.

HCA Healthcare (US40412C1018) is trading close to its recent highs on the New York Stock Exchange this week. The hospital operator’s Thursday chart setup shows a relatively tight intraday range and moderate volatility, based on publicly available quote data.

What the latest quotes show

On Thursday, HCA Healthcare shares recently changed hands around $375 on the NYSE, after trading between roughly $375.50 and $391.47 during the session according to a real-time quote overview from Robinhood. That leaves the stock just under 4% below the day’s high.

The same data set implies a market capitalization in the low $80 billion range, reflecting HCA’s position as a leading US hospital operator. The quoted price-to-earnings ratio in the low-teens and a dividend yield below 1% underline that the stock is valued as a mature but still growing healthcare services business.

Technical picture on a Thursday

From a chart perspective, the narrow intraday range this Thursday suggests contained volatility after a strong medium-term run in the shares. Over the past twelve months, HCA Healthcare stock has outperformed many broader US equity benchmarks and several hospital peers, according to analyst overviews compiled by Bitget.

That performance has come alongside increasing patient volumes and operational efficiency improvements within the company’s hospital network, which analysts identify as key drivers for earnings and cash flow. Against this backdrop, Thursday’s trading action fits into a broader trend of robust but not overheated momentum.

Analyst stance and valuation context

Analyst commentary aggregated by Bitget indicates a predominantly bullish stance on HCA Healthcare, with few major sell ratings from large institutions and an average target price in the mid-$300s as of early 2024. High-end targets cited by firms such as Wells Fargo have reached about $360, based on expectations for strong free cash flow and potential earnings beats.

Those earlier targets have already been met and partly exceeded by the current share price region, which puts the spotlight on updated models and the next official guidance from management. For now, the valuation framework implies that the market is pricing in continued stable growth without an extreme speculative premium.

How HCA generates revenue

HCA Healthcare operates one of the largest private hospital networks in the United States, with more than 180 hospitals and around 2,300 care sites including surgery centers, freestanding emergency rooms and physician clinics, according to the company’s corporate overview. Revenue is primarily generated from inpatient and outpatient services reimbursed by commercial insurers, government programs and self-pay patients.

The company also invests in technology-enabled care, including data-driven clinical decision support and telehealth offerings, to improve efficiency and patient outcomes. This operational scale and integrated model help explain the stock’s role as a core healthcare name in many institutional portfolios.

Where the stock trades today

HCA Healthcare shares (US40412C1018) trade on the New York Stock Exchange at $375.63 as of 06/18/2026, 21:31 CET.

Key facts on HCA Healthcare stock

• Company: HCA Healthcare, Inc.
• ISIN: US40412C1018
• WKN: A1JT1B
• Ticker: HCA
• Venue: NYSE
• Price (as of 06/18/2026, 21:31 CET): 375.63 USD
• Market cap: 83.33 billion USD (as of 06/18/2026)
• Sector / Industry: Health Care / Hospital Operators
• Index membership: Standard & Poor's 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.